US2021361185A1PendingUtilityA1
Electrical impedance myography
Assignee: BETH ISRAEL DEACONESS MEDICAL CT INCPriority: Feb 14, 2014Filed: Apr 12, 2021Published: Nov 25, 2021
Est. expiryFeb 14, 2034(~7.6 yrs left)· nominal 20-yr term from priority
A61B 5/053A61B 5/6843A61B 5/4519A61B 5/0537
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Electrical impedance myography (EIM) can be used for assessment and diagnosis of muscular disorders. EIM includes applying an electrical signal to a region of tissue and measuring a resulting signal. A characteristic of the region of tissue is determined based on the measurement. Performing EIM at different frequencies and modeling one or more impedance metrics as a function of frequency may provide impedance model parameters that can aid in the assessment and diagnosis. Devices are described that facilitate assessment and diagnosis using EIM.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 - 14 . (canceled)
15 . A method for performing an impedance measurement for biological tissue having at least two cell types, the method comprising:
positioning a first pair of electrodes on the biological tissue along a first axis; positioning a second pair of electrodes on the biological tissue along the first axis and between the first pair of electrodes; controlling an alternating current in the first pair of electrodes; varying the frequency of the alternating current over a plurality of frequency values; measuring at least one voltage from the second pair of electrodes; determining a plurality of impedance measurements based on the alternating current over a plurality of frequency values and the at least one voltage; and calculating a ratio of the plurality of impedance measurements.
16 . The method of claim 15 , wherein the plurality of frequency values include a first frequency and a second frequency, the first frequency produces a first impedance measurement optimized for a first cell type, the second frequency produces a second impedance measurement optimized for a second cell type.
17 . The method of claim 16 , wherein the first cell type is muscle and the second cell type is fat.
18 . The method of claim 17 , wherein the first frequency is 50 kHz and the second frequency is 200 kHz.
19 . The method of claim 15 , wherein the plurality of impedance measurements are phase values.
20 . The method of 15 , wherein the plurality of frequency values are 50 kHz and 200 kHz.
21 . A method for measuring impedance of biological tissue in an organism, the method comprising:
contacting an electrode array to the biological tissue, the electrode array having a plurality of electrodes; controlling an AC input signal to the electrode array; measuring an output signal from the electrode array; determining at least one impedance measurement based on the input signal and output signal; determining a status of the biological tissue based on the at least one impedance measurement; and determining a status of the organism based on the at least one impedance measurement.
22 . The method of claim 21 , wherein the biological tissue is a tongue of an organism.
23 . The method of claim 22 , wherein the status of the biological tissue is a condition of the tongue.
24 . The method of claim 21 , wherein the biological tissue is facial muscle of an organism.
25 . The method of claim 21 , wherein the at least one impedance measurement is a phase value.
26 . The method of claim 21 , wherein the status of the organism is a measure of disease severity.
27 . The method of claim 26 , wherein the measure of disease severity is bulbar dysfunction when the organism has amyotrophic lateral sclerosis (ALS).Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.